Skip to main content

Table 1 TILs from Pancreatic Adenocarcinoma are Predominantly CD4+

From: Expansion of tumor-infiltrating lymphocytes (TIL) from human pancreatic tumors

Patient CD4+ CD8+ Fragments plated TIL yield Yield per 48 fragments
1 31.8 54.3 4 4.97E + 05 5.96E + 06
2 95.4 4.04 9 1.40E + 08 7.47E + 08
3 96.9 1.90 24 1.13E + 07 2.26E + 07
4 96.6 1.34 24 6.40E + 05 1.28E + 06
5 64.0 33.5 23 3.78E + 07 7.89E + 07
6 72.0 21.7 24 2.52E + 07 5.04E + 07
7 60.2 33.0 33 5.32E + 06 7.74E + 06
8 74.5 22.8 12 1.42E + 06 5.68E + 06
9 92.1 5.79 36 3.64E + 07 4.85E + 07
10 41.3 46.5 10 5.90E + 06 2.83E + 07
11 a a 9 N/A N/A
12 52.4 34.4 24 ND ND
13 85.1 12.6 1 2.92E + 06 1.40E + 08
14 49.9 17.9 12 1.80E + 06 7.20E + 06
15 36.9 49.5 5 1.34E + 06 1.29E + 07
16 55.8 38.6 2 6.90E + 05 1.66E + 07
17 60.1 24.2 1 ND ND
18 67.9 28.7 7 2.37E + 07 1.63E + 08
19 80.7 9.02 14 1.89E + 06 4.68E + 07
20 41.6 47.1 12 7.50E + 06 7.50E + 06
Mean 66.1 25.6 14.3 1.79E + 07 8.31E + 07
SD 21.0 17.0 10.5   
  1. All TIL analyzed are pre-Rapid Expansion Protocol (REP)
  2. a TIL growth not observed; N/A not applicable, ND no data